Literature DB >> 10878585

Pro-apoptotic action of PAR-4 involves inhibition of NF-kappaB activity and suppression of BCL-2 expression.

S Camandola1, M P Mattson.   

Abstract

Par-4(1) (prostate apoptosis response 4) is known to function at an early stage in apoptosis in several different cell types, including neurons. On the other hand, activation of the transcription factor NF-kappaB can prevent apoptosis in various cancer cells and neurons. We now report that overexpression of full-length Par-4 in cultured PC12 cells results in a suppression of basal NF-kappaB DNA-binding activity and NF-kappaB activation following trophic factor withdrawal (TFW). The decreased NF-kappaB activity is correlated with enhanced apoptosis. Conversely, NF-kappaB activity is increased and vulnerability to apoptosis reduced in cells overexpressing a dominant-negative form of Par-4. Par-4 overexpression or functional blockade had no effect on AP-1 DNA-binding activity. Expression of the antiapoptotic protein Bcl-2 was dramatically reduced in PC12 cells overexpressing Par-4. Our data suggest that suppression of NF-kappaB activation plays a major role in the proapoptotic function of Par-4. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10878585     DOI: 10.1002/1097-4547(20000715)61:2<134::AID-JNR3>3.0.CO;2-P

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  15 in total

1.  pH-induced folding of an apoptotic coiled coil.

Authors:  K Dutta; A Alexandrov; H Huang; S M Pascal
Journal:  Protein Sci       Date:  2001-12       Impact factor: 6.725

Review 2.  Do apoptotic mechanisms regulate synaptic plasticity and growth-cone motility?

Authors:  Charles P Gilman; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

Review 3.  Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders.

Authors:  Vittorio Calabrese; Carolin Cornelius; Albena T Dinkova-Kostova; Edward J Calabrese; Mark P Mattson
Journal:  Antioxid Redox Signal       Date:  2010-08-28       Impact factor: 8.401

Review 4.  NF-kappaB in the survival and plasticity of neurons.

Authors:  Mark P Mattson
Journal:  Neurochem Res       Date:  2005 Jun-Jul       Impact factor: 3.996

Review 5.  Mechanisms of apoptosis during reovirus infection.

Authors:  P Clarke; S M Richardson-Burns; R L DeBiasi; K L Tyler
Journal:  Curr Top Microbiol Immunol       Date:  2005       Impact factor: 4.291

6.  Kainic acid-induced neuronal cell death in cerebellar granule cells is not prevented by caspase inhibitors.

Authors:  Ester Verdaguer; Elvira García-Jordà; Andrés Jiménez; Alessandra Stranges; Francesc X Sureda; Anna M Canudas; Elena Escubedo; Jordi Camarasa; Mercè Pallàs; Antoni Camins
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

7.  ZIP kinase triggers apoptosis from nuclear PML oncogenic domains.

Authors:  Taro Kawai; Shizuo Akira; John C Reed
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

8.  Lipopolysaccharide mitagates methamphetamine-induced striatal dopamine depletion via modulating local TNF-alpha and dopamine transporter expression.

Authors:  Yu-Ting Lai; Yen-Ping N Tsai; Chianfang G Cherng; Jing-Jer Ke; Ming-Che Ho; Chia-Wen Tsai; Lung Yu
Journal:  J Neural Transm (Vienna)       Date:  2009-03-07       Impact factor: 3.575

9.  Reovirus-induced alteration in expression of apoptosis and DNA repair genes with potential roles in viral pathogenesis.

Authors:  Roberta L DeBiasi; Penny Clarke; Suzanne Meintzer; Robert Jotte; B K Kleinschmidt-Demasters; Gary L Johnson; Kenneth L Tyler
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

10.  Pro-apoptotic Par-4 and dopamine D2 receptor in temporal cortex in schizophrenia, bipolar disorder and major depression.

Authors:  Leisa A Glantz; John H Gilmore; David H Overstreet; Kayvon Salimi; Jeffrey A Lieberman; L Fredrik Jarskog
Journal:  Schizophr Res       Date:  2010-01-13       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.